Prognostic and clinicopathological impacts of Controlling Nutritional Status (CONUT) score on patients with gynecological cancer: a meta-analysis

被引:0
作者
Zheng Niu
Bing Yan
机构
[1] Affiliated Hangzhou First People’s Hospital,Department of Gynecology
[2] Zhejiang University School of Medicine,Department of Pharmacy
[3] The First Affiliated Hospital of Huzhou University,undefined
来源
Nutrition Journal | / 22卷
关键词
CONUT; Meta-analysis; Gynecological cancer; Prognosis; Evidence-based medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 160 条
  • [1] Wang D(2022)New progress and challenge in gynecological cancer Ann Transl Med 10 119-2270
  • [2] Yoshida Y(2021)Clinical management of chemotherapy for elderly gynecological cancer patients J Obstet Gynaecol Res 47 2261-844
  • [3] Inoue D(2019)Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer Sci Rep 9 3284-41
  • [4] Huang H(2019)Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients Clin Transl Oncol 21 836-82
  • [5] Liu Q(2021)Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer Pathol Oncol Res 27 1609946-98
  • [6] Zhu L(2018)Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS) Gynecol Oncol 148 36-769
  • [7] Zhang Y(2018)The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer BMC Cancer 18 883-67
  • [8] Lu X(2020)Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer Int J Gynecol Cancer 30 74-671
  • [9] Wu Y(2021)Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: Results from a retrospective cohort study Gynecol Oncol 160 91-1779
  • [10] Liu L(2021)Preoperative controlling nutritional status (CONUT) score is a prognostic factor for early-stage cervical cancer patients with high-risk factors Gynecol Oncol 162 763-1012